OMB# 0925-0766
Exp. 4/30/2023
Public reporting burden for this collection of information is estimated to average 60 minutes per
response, including the time for reviewing instructions, searching existing data sources, gathering and
maintaining the data needed, and completing and reviewing the collection of information. An agency may
not conduct or sponsor, and a person is not required to respond to, a collection of information unless it
displays a currently valid OMB control number. Send comments regarding this burden estimate or any
other aspect of this collection of information, including suggestions for reducing this burden, to: NIH,
Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA
(0925-0766). Do not return the completed form to this address.
COPD National Action Plan Collaboration and Tracking System — Preliminary Model
Please share your activity or initiative in support of the National Action Plan. Report only one activity per form submission.
Name
of the
activity
Name
Organization
(for this activity)
Role
in organization
City/Town
State/Province
Email
Address
Phone
Number
Which best describes you or your organization?
Advocacy
organization/non-profit
Health
professional organization
Health care
provider
Industry
Federal, state, or
local government agency
Academic
institution
Policymaker
Other (please
describe)
Briefly describe your activity and how it contributes to the goals and objectives of the COPD National Action Plan.
Summary
(max 1500
characters)
Include
any links where people can learn
more
(websites, social media, journal articles, etc.).
Which goal of the National Action Plan does this activity best align with? While an organization might address multiple goals, each individual activity usually focuses most strongly on one. If this activity has a strong focus on more than one goal, please choose a primary and up to two secondary goals.
|
Primary |
|
Secondary |
1: Empower people with COPD, their families, and caregivers to recognize and reduce the burden of COPD. |
|
|
|
2: Improve the prevention, diagnosis, treatment, and management of COPD by improving the quality of care delivered across the health care continuum. |
|
|
|
3: Collect, analyze, report, and disseminate COPD-related public health data that drive change and track progress. |
|
|
|
4: Increase and sustain research to better understand the prevention, pathogenesis, diagnosis, treatment, and management of COPD. |
|
|
|
5: Translate national policy, educational, and program recommendations into research and public health care actions. |
|
|
|
Items 7-11 list objectives of each goal.
Please select only objectives corresponding to the goal(s) you
selected above, then continue on page 5.
Increase
public awareness
of the
risk factors
and symptoms
of COPD
so that
earlier diagnosis
of symptomatic
individuals becomes the
norm
Increase
the effectiveness and variety of outreach communication campaigns and
activities that utilize evidence-based approaches
to raise
awareness of
COPD, particularly
among those
at high
risk, and
help people
diagnosed with
COPD manage the
disease
Expand
opportunities to increase COPD awareness across the public-private
spectrum
Develop,
disseminate, and
maintain unified,
multidisciplinary, and
patient-centric national
guidelines for
COPD that
are accessible and easy to
follow
Develop
a unified,
multidisciplinary
educational curriculum
for health
care professionals,
including primary
health care
providers, using harmonized clinical practice
guidelines
Develop,
in accordance
with clinical
quality measures,
a clinical
decision tree
and other
tools to
enable high-quality
care for people
with COPD
Develop
and encourage
the use
of a
written, patient-centric
COPD management
plan tool,
with appropriate
cultural and
health literacy
considerations, which
can be
customized with
input from
the patient's
health care
provider(s)
Improve
access to care for people with COPD, particularly for those in
hard-to reach areas
Enhance
and optimize
our capacity
to collect
and aggregate
data from
multiple sources,
including at
local, regional,
and national
levels, and turn them into actionable
information.
Facilitate
dissemination of
data and
analyses. Report the
prevalence of
COPD in
accordance with
the requirements
of public health
and health care organizations
Help
expand, coordinate, and optimize COPD research efforts
Improve
methods for
earliest detection
and diagnosis
and develop
effective strategies
for preventing
the onset
and progression
of COPD
Define
and characterize the pathogenesis of COPD heterogeneity
Develop
personalized medicine for COPD based on the pathogenesis and clinical
heterogeneity
Promote
research that
can lead
to strategies
that help
prevent the
onset and
progression of
COPD and
improve the
quality of COPD
care and management
Put
into action prevention strategies that are proven effective in
addressing the 80 percent of COPD deaths due to smoking
Create
a collaborative
official entity
that implements,
prioritizes, and
tracks activities
in accordance
with the
COPD National
Action Plan's goals and
objectives
Identify
and publicize
funding opportunities
that advance
the implementation
of the
COPD National
Action Plan
Develop and implement COPD quality measures into national care
delivery
Strengthen the public health infrastructure for addressing COPD
Patients
Caregivers,
family members
At-risk
populations (history
of smoking,
workplace exposure
to lung irritants, alpha-1 antitrypsin
deficiency)
General
public
Other
(please describe)
Health professionals Employers Researchers Policymakers
|
Hispanic |
|
Men |
|
Non-Hispanic American Indian or Alaska Native |
|
Women |
|
Non-Hispanic Asian or Pacific Islander |
|
|
|
Non-Hispanic Black |
|
|
|
Non-Hispanic White
|
|
Other (please describe below) |
|
|
|
|
Patient
education
Event
Campaign
Healthcare delivery
Material or product (indicate type — print, audio, visual, etc. — under other)
Provider education
Research
Service Support group Training
Other (please describe)
When
did it
start? (Month and
year)
When did it stop, or is it ongoing?
Ongoing
Stop date (Month and
year)
What area(s) of the country does your activity cover?
Geographic location (Choose all that apply) 18. Type of area (Choose all that apply)
|
National |
|
Urban |
|
Regional (multi-state; indicate states: _________________________________) |
|
Suburban |
|
State (indicate state: ________________) |
|
Rural |
|
Local (indicate state: ________________) |
|
|
|
Other (please describe below) |
|
|
|
|
|
|
Community
Health care
Home
Workplace
Online
Other (please
specify)
We
worked alone
We
worked with the following organization(s) or individual(s)
Please describe how much this activity cost and its funding sources.
What impact has your activity had so far? (Include quantitative data if available, such as analytics, number of attendees or enrollees, quantities distributed or downloaded, etc.)
What
advice or lessons learned do you have for anyone considering a
similar activity?
What
role
did
the
COPD
National
Action
Plan
play
in
helping
you
develop
the
activity
(e.g., provide
ideas, lead to new collaborations or funding,
etc.)?
Yes
No
Draft
— February 6, 2020
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
File Title | View Survey |
Author | Ammary-Risch, Neyal (NIH/NHLBI) [E] |
File Modified | 0000-00-00 |
File Created | 2021-01-14 |